Actin polymerization in neutrophils from donors of peripheral blood stem cells: Divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor

American Journal of Hematology

Volumn 81, Issue 5, 2006, Pages 318-323

  Carulli, Giovanni ^a,b   Mattii, Letizia ^a   Azzarà, Antonio ^a   Brizzi, Stefania ^a   Galimberti, Sara ^a   Zucca, Alessandra ^a   Benedetti, Edoardo ^a   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Actin; Actin polymerization; Neutrophils; rhG CSF

Indexed keywords

ACTIN; F ACTIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLYCOSYLATED RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; MYELOSTIM34; NEUPOGEN30; NONGLYCOSYLATED RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BACTERICIDAL ACTIVITY; BLOOD DONOR; CELL MEMBRANE; CELL STRUCTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; LEUKOCYTE MOTILITY; MALE; NEUTROPHIL; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; STEM CELL DONOR; STEM CELL MOBILIZATION;

ACTINS; ADULT; ANTIGENS, CD34; BLOOD DONORS; FEMALE; FILGRASTIM; FLOW CYTOMETRY; GLYCOSYLATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INJECTIONS, SUBCUTANEOUS; LEUKOCYTE COUNT; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEUTROPHILS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECOMBINANT PROTEINS;

EID: 33646487172     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20604     Document Type: Article

References (21)

1. Carlsson G, Ahlin A, Dahllof G, Elinder G, Henter J-I, Palmblad J. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia. Br J Haematol 2004;126:127-132.
2. Carulli G. Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and function. Haematologica 1997;82:606-616.
3. Carulli G, Minnucci S, Azzarà A, Angiolini C, Sbrana S, Caracciolo F, Ambrogi F. Granulocyte colony-stimulating factor increases CD32 (FcRII) expression and FcR-related functions. Haematologica 1995;80:150-154.
4. Azzarà A, Carulli G, Rizzuti-Gullaci A, Minnucci S, Capochiani E, Ambrogi F. Motility of rhG-CSF-induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis. Br J Haematol 1996;92:161-168.
5. Leavy PJ, Sellins KS, Thurman G, Elzi D, Hiester A, Silliman CC, Zerbe G, Cohen JJ, Ambruso DR. In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood 1998;92:4366-4374.
6. Dunn CJ, Goa KL. lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings. Drugs 2000;59:681-717.
7. Bonig H, Silbermann S, Weller S, Kirschke R, Korholz D, Janssen G, Gobel U, Nurnberger W. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)-results of a prospective randomised monocentre study. Bone Marrow Transplant 2001;28:259-264.
8. Martin-Christin F. Granulocyte colony-stimulating factors: how different are they? How to make a decision? Anticancer Drugs 2001;12:185-191.
9. De Arriba F, Lozano ML, Ortuno F, Heras I, Moraleda JM, Vicente V. Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG-CSF for mobilizing peripheral blood progenitor cells. Br J Haematol 1997;96:418-420.
10. Kim IH, Park SK, Suh OK, Oh JM. Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose therapy. Curr Med Res Opin 2003;19:753-759.
11. Azzarà A, Carulli G. Morphological features following G-CSF treatment. Haematologica 1997;504-505.
12. Azzarà A, Carulli G, Rizzuti-Gullaci A, Capochiani E, Petrini M. lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis. Am J Hematol 2001;66:306-307.
13. Niggli V. Signaling to migration in neutrophils: importance of localized pathways. Int J Biochem Cell Biol 2003;35:1619-1638.
14. Cicchetti G, Allen PG, Glogauer M. Chemotactic signaling pathways in neutrophils: from receptor to actin assembly. Crit Rev Oral Biol Med 2003;13:220-228.
15. Carulli G, Minnucci S, Gianfaldoni ML, Angiolini C, Azzarà A, Ambrogi F. Interactions between platelets and neutrophils in essential thrombocythemia. Effects on neutrophil chemiluminescence and superoxide anion generation. Eur J Clin Invest 1995;25:929-938.
16. Howard TH, Oresajo CO. The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils. J Cell Biol 1985;101:1078-1085.
17. Carulli G, Sbrana S, Minnucci S, Azzarà A, Angiolini C, Rizzati Gullaci A, Ambrogi F. Actin polymerization in neutrophils from patients affected by myelodysplastic syndromes. A flow cytometric study. Leukemia Res 1997;21:513-518.
18. Mattii L, Fazzi R, Moscato S, Segnani C, Pacini S, Galimberti S, D'Alessandro D, Bernardini N, Petrini M. Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA. J Cell Biochem 2004;99:1231-1241.
19. Weiner OD. Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass. Curr Opin Cell Biol 2002;14:196-202.
20. Watts RG, Howard TH. Mechanisms for actin reorganization in chemotactic factor-activated polymorphonuclear leukocytes. Blood 1993;81:2750-2757.
21. Torres M, Coates TD. Function of the cytoskeleton in human neutrophils and methods for evaluation. J Immunol Methods 1999;232:89-109.